Sunshine Biopharma (SBFM) Total Non-Current Liabilities (2018 - 2025)
Historic Total Non-Current Liabilities for Sunshine Biopharma (SBFM) over the last 8 years, with Q3 2025 value amounting to $636708.0.
- Sunshine Biopharma's Total Non-Current Liabilities rose 3019.89% to $636708.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $636708.0, marking a year-over-year increase of 3019.89%. This contributed to the annual value of $744724.0 for FY2024, which is 2670.46% up from last year.
- Per Sunshine Biopharma's latest filing, its Total Non-Current Liabilities stood at $636708.0 for Q3 2025, which was up 3019.89% from $706530.0 recorded in Q2 2025.
- Over the past 5 years, Sunshine Biopharma's Total Non-Current Liabilities peaked at $744724.0 during Q4 2024, and registered a low of $489027.0 during Q3 2024.
- Over the past 4 years, Sunshine Biopharma's median Total Non-Current Liabilities value was $638295.0 (recorded in 2023), while the average stood at $627026.4.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 2004.23% in 2024, then soared by 3809.26% in 2025.
- Sunshine Biopharma's Total Non-Current Liabilities (Quarter) stood at $685264.0 in 2022, then fell by 14.23% to $587764.0 in 2023, then grew by 26.7% to $744724.0 in 2024, then fell by 14.5% to $636708.0 in 2025.
- Its last three reported values are $636708.0 in Q3 2025, $706530.0 for Q2 2025, and $722199.0 during Q1 2025.